Search results
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
Investing.com· 6 days agoLungs of young adults more susceptible to SARS-CoV-2 virus: Study
Physicist Studying SARS-CoV-2 Virus Believes He Has Found Hints We Are Living In A Simulation
IFLScience· 7 days agoA physicist studying mutations of the SARS-CoV-2 virus claims to have found evidence for a new law...
Newly Discovered Prehistoric Snake May Be Largest To Ever Exist, Vaccine Breakthrough Could Mean...
IFLScience· 4 days agoThis week, a physicist studying the SARS-CoV-2 virus believes he’s found evidence that we’re living...
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
SciTechDaily· 2 days agoThe SARS-CoV-2 virus that causes COVID has the unsettling ability of often generating variants of...
Tri-State clinics and trials help patients with long COVID
Local 12 Cincinnati· 12 hours agoWhile new cases of the novel SARS-CoV-2 virus are down, infectious disease specialist Dr. Stephen...
UK virtually ends free vaccines as COVID-19 continues to spread
World Socialist Web Site· 2 days agoConsequently, the SARS-COV-2 virus still infects tens of thousands weekly, leading to hundreds of...
WHO clarifies terminology for air-transmitted pathogens
Medical Xpress· 6 days agoDuring the COVID-19 crisis the standoff between experts arguing over whether the SARS-CoV-2 virus...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 9 hours agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...
Moderna seals vaccine deal with Brazil's Health Ministry By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) has secured a contract with Brazil's Ministry of Health to supply 12.5...
Xencor (NASDAQ:XNCR) Price Target Cut to $38.00
ETF DAILY NEWS· 6 days agoXencor (NASDAQ:XNCR – Get Free Report) had its target price lowered by analysts at BTIG Research from $56.00 to $38.00 in a research report issued to clients and investors on Tuesday, MarketBeat.com ...